These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 2815696)

  • 1. [The prevention of the side effects of cytostatics by administering them at various times of day].
    Efimov ML; Vasil'eva GS; Kovalenko VR; Panina TG; Mustafina RKh
    Vopr Onkol; 1989; 35(9):1068-71. PubMed ID: 2815696
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [The effect of the time of methotrexate administration over 24 hours on the antitumor activity of the preparation, its concentration in the blood and in the tumor in Pliss' lymphosarcoma in rats].
    Efimov ML; Vasil'eva GS; Malysheva LA; Abdullin KA
    Vopr Onkol; 1992; 38(9):1085-9. PubMed ID: 1300822
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of cyclophosphane on polyamine excretion in rats with Guérin's carcinoma and Pliss' lymphosarcoma].
    Berdinskikh NK; Draga NV; Zaletok SP
    Eksp Onkol; 1989; 11(3):69-72. PubMed ID: 2752948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A method for choosing preparations that reduce the toxicity of cytostatics in experimental chemotherapy of tumors].
    Zueva EP; Iaremenko KV
    Farmakol Toksikol; 1989; 52(1):74-7. PubMed ID: 2707428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Effect of methylglyoxal bis(guanylhydrazone) in combination with antifolic acid preparations on the biochemical indices and growth of Pliss lymphosarcoma in rats].
    Bukin IuV; Lukienko EP
    Vopr Onkol; 1986; 32(2):61-6. PubMed ID: 3754363
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacological correction of the cytogenetic effect of cyclophosphane].
    Voronova OL; Pashinskiĭ VG
    Vopr Onkol; 1991; 37(2):233-5. PubMed ID: 2014709
    [No Abstract]   [Full Text] [Related]  

  • 7. Evaluation of some prognostic factors for advanced multicentric lymphosarcoma in the dog: 147 cases (1978-1981).
    MacEwen EG; Hayes AA; Matus RE; Kurzman I
    J Am Vet Med Assoc; 1987 Mar; 190(5):564-8. PubMed ID: 3558097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The mechanism of the formation of a circadian rhythm of bone marrow proliferation in rats].
    Blank MA; Gushchin VA; Tokalov SV; Korytova LI; Lubotskaia LS; Klestova OV; Iagunov AS
    Vopr Onkol; 1991; 37(9-10):941-8. PubMed ID: 1842654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Comparative evaluation of the cytogenetic effect of cyclophosphamide on lymphosarcoma cells and the bone marrow of intact and irradiated rats].
    Iakovleva TK
    Vopr Onkol; 1986; 32(7):67-71. PubMed ID: 3755558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Decrease in the growth rate of Ehrlich's tumor and Pliss' lymphosarcoma with partial hepatectomy].
    Udintsev SN; Shakhov VP
    Vopr Onkol; 1989; 35(9):1072-5. PubMed ID: 2573197
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronotoxicity of methotrexate in mice after intraperitoneal administration.
    Labat C; Mansour K; Malmary MF; Terrissol M; Oustrin J
    Chronobiologia; 1987; 14(3):267-75. PubMed ID: 3677924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A variant of ProMACE-CytaBOM chemotherapy for non-Hodgkin's lymphoma with threefold higher drug dose size but identical cumulative dose intensity. A pilot study of the Italian lymphoma study group (GISL).
    Gobbi PG; Ghirardelli ML; Avanzini P; Baldini L; Quarta G; Stelitano C; Broglia C; Loni C; Silingardi V; Ascari E
    Haematologica; 2000 Mar; 85(3):263-8. PubMed ID: 10702814
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The use of protein as a carrier of methotrexate for experimental cancer chemotherapy. III. Human serum albumin-methotrexate derivative, its preparation and basic testing.
    Bures L; Bostík J; Motycka K; Spundová M; Rehák L
    Neoplasma; 1988; 35(3):329-42. PubMed ID: 3405341
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Evaluation of the results of treatment of non-Hodgkin's lymphoma in children by the Wollner method].
    Dłuzewska A; Armata J
    Pol Tyg Lek; 1988 Jul; 43(28):906-9. PubMed ID: 3247260
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cyclophosphamide-induced apoptosis of murine lymphosarcoma cells in vivo].
    Kaledin VI; Nikolin VP; Ageeva TA; Timofeeva OA; Filipenko ML; Ronichevskaia GM; Morozkova TS; Popova NA; Baĭmak TIu
    Vopr Onkol; 2000; 46(5):588-93. PubMed ID: 11202193
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Circadian rhythm of adenosine triphosphatase activity and 32P content in Pliss lymphosarcoma].
    Seĭtkazina GD; Vasil'eva GS; Efimov ML; Kovalenko VR
    Vopr Med Khim; 1984; 30(6):38-40. PubMed ID: 6152086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ifosfamide, methotrexate, and vincristine (IMV) combination chemotherapy as secondary treatment for patients with malignant lymphoma.
    Cabanillas F; Rodriguez V; Bodey GP
    Cancer Treat Rep; 1980; 64(8-9):933-7. PubMed ID: 7004634
    [No Abstract]   [Full Text] [Related]  

  • 18. [Circadian rhythm studies on the prenatal toxic effect of cyclophosphamide and centrophenoxine in Wistar rats].
    Neumann HJ; Hollnack W; Hollnack B; Frömmel H
    Anat Anz; 1985; 160(5):345-52. PubMed ID: 3938189
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II multicenter trial of high-dose sequential chemotherapy and peripheral blood stem cell transplantation as initial therapy for patients with high-risk non-Hodgkin's lymphoma.
    Schenkein DP; Roitman D; Miller KB; Morelli J; Stadtmauer E; Pecora AL; Cassileth P; Fernandez H; Cooper BW; Kutteh L; Lazarus HM
    Biol Blood Marrow Transplant; 1997 Oct; 3(4):210-6. PubMed ID: 9360783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experimental toxicologic and therapeutic studies on the activity of the CMF(cyclophosphamide-methotrexate-5-fluorouracil) scheme versus the VMF(vincristine-methotrexate-5-fluorouracil) scheme].
    Berger MR; Habs M; Schmähl D
    Arch Geschwulstforsch; 1984; 54(4):263-78. PubMed ID: 6548622
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.